NCT04793126

Brief Summary

To assess the urinary symptoms and urodynamic findings concomitant with Pelvic organ prolapse before and after surgical treatment and to define the role of urodynamic study in treatment decision making.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Dec 2014

Typical duration for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 11, 2021

Completed
Last Updated

March 11, 2021

Status Verified

March 1, 2021

Enrollment Period

1.6 years

First QC Date

March 9, 2021

Last Update Submit

March 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Urodynamic study evaluation for the participants

    evaluation of the urodynamic study after the surgical repair of the pelvic organ prolapse and comparison to the preoperative results.

    6 month after the procedure

Interventions

Urodynamic studyDIAGNOSTIC_TEST

comparison between the urodynamic study of the patients before pelvic prolapse surgical repair and 6 months later.

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPelvic organ prolapse surgeries
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • women with anterior pelvic organ prolapse (POP) associated with Lower urinary tract symptoms

You may not qualify if:

  • Patients with POP less than POP-Q grade II, POP not in need for surgical repair, neurological diseases that could possibly affect voiding functions, pelvic infections, congenital bladder disorders, history of urinary fistula, history of malignancy, and patients on current medical treatment for voiding dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: All patients were subjected to clinical evaluation and urodynamic testing before surgery. All cases underwent surgical repair of pelvic organ prolapse. Follow-up clinical examination was performed at 1, 3, and 6 months postoperatively, and urodynamic examination was repeated 6 months after repair.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

March 9, 2021

First Posted

March 11, 2021

Study Start

December 1, 2014

Primary Completion

July 1, 2016

Study Completion

December 1, 2018

Last Updated

March 11, 2021

Record last verified: 2021-03